Custom Services

Tailored enzyme solutions

Custom Services

Tailored enzyme solutions

We leverage our cutting-edge platform and technology to help you reduce costs, increase efficiency, and maximize profitability.

Case 1

Pharma Manufacturing Customer:

$24M New Profit

50% Cost Reduction

Case 2

Diagnostic Industry Customer:

$45M New Revenue

120% Revenue Increase

CASE STUDY
An enzyme engineering biocatalysis case from a pharma client
Problem
The customer already uses an enzymatic step to synthesize a small molecule. But the the enzyme activity is low
From the substrate to the product both the conversion rate and the e.e. value have to be greater than 99%, increase enzyme activity by at least 250%
Pando Customer Value Proposition:
In just one round, within the first quarter of the project, our engineered enzyme increased enzymatic activity by over 500% while maintaining the conversion rate and e.e. value > 99%
All enzymes have FTO and no prior-art
CASE STUDY
A polymerase case from a diagnostics client
Problem
The customer wants a better novel polymerase for Library preparation for NGS
Crowded IP space
Need to precisely identify different sequence patterns in novel enzymes and remove them
Pando Customer Value Proposition:
In 4 months, we have demonstrate 22% of designed proteins showed significant activity, top 4% are already comparable to the market leaders in thermostability, processivity, speed, and fidelity
All enzymes have FTO and no prior-art
CASE STUDY
Metagenomic sourcing biocatalysis cases from pharma clients
Problem
The customer uses 17 chemical steps to synthesize a generic drug. The manufacturing cost is very high
The current substrate is very expensive, the customer made a cheap substitute, but the chemical step can not convert the cheaper substrate to the correct product
Pando Customer Value Proposition:
We replaced 11 chemical steps with one enzymatic step, and enabled our pharma customer to project a 50% reduction in manufacturing costs, increasing their profit margin by $24M per year
We identify enzymes to realize enzymatic conversion of this novel cheap substrate to the correct product

CASE STUDY
A polymerase case from a diagnostics client
Problem
The customer wants a better novel polymerase for Library preparation for NGS
Crowded IP space
Need to precisely identify different sequence patterns in novel enzymes and remove them
Pando Customer Value Proposition:
In 4 months, we have demonstrate 22% of designed proteins showed significant activity, top 4% are already comparable to the market leaders in thermostability, processivity, speed, and fidelity
All enzymes have FTO and no prior-art
CASE STUDY
An enzyme engineering biocatalysiscase from a pharma client
Problem
The customer already uses an enzymatic step to synthesize a small molecule. But the the enzyme activity is low
From the substrate to the product both the conversion rate and the e.e. value have to be greater than 99%, increase enzyme activity by at least 250%
Pando Customer Value Proposition:
In just one round, within the first quarter of the project, our engineered enzyme increased enzymatic activity by over 500% while maintaining the conversion rate and e.e. value > 99%
All enzymes have FTO and no prior-art
CASE STUDY
Metagenomic sourcing biocatalysis cases from pharma clients
Problem
The customer uses 17 chemical steps to synthesize a generic drug. The manufacturing cost is very high
The current substrate is very expensive, the customer made a cheap substitute, but the chemical step can not convert the cheaper substrate to the correct product.
Pando Customer Value Proposition:
We replaced 11 chemical steps with one enzymatic step, and enabled our pharma customer to project a 50% reduction in manufacturing costs, increasing their profit margin by $24M per year
We identify enzymes to realize enzymatic conversion of this novel cheap substrate to the correct product

CASE STUDY
A polymerase case from a diagnostics client
Problem
The customer wants a better novel polymerase for Library preparation for NGS
Crowded IP space
Need to precisely identify different sequence patterns in novel enzymes and remove them
Pando Customer Value Proposition:
In 4 months, we have demonstrate 22% of designed proteins showed significant activity, top 4% are already comparable to the market leaders in thermostability, processivity, speed, and fidelity
All enzymes have FTO and no prior-art
CASE STUDY
An enzyme engineering biocatalysiscase from a pharma client
Problem
The customer already uses an enzymatic step to synthesize a small molecule. But the the enzyme activity is low
From the substrate to the product both the conversion rate and the e.e. value have to be greater than 99%, increase enzyme activity by at least 250%
Pando Customer Value Proposition:
In just one round, within the first quarter of the project, our engineered enzyme increased enzymatic activity by over 500% while maintaining the conversion rate and e.e. value > 99%
All enzymes have FTO and no prior-art
CASE STUDY
Metagenomic sourcing biocatalysis cases from pharma clients
Problem
The customer uses 17 chemical steps to synthesize a generic drug. The manufacturing cost is very high
The current substrate is very expensive, the customer made a cheap substitute, but the chemical step can not convert the cheaper substrate to the correct product.
Pando Customer Value Proposition:
We replaced 11 chemical steps with one enzymatic step, and enabled our pharma customer to project a 50% reduction in manufacturing costs, increasing their profit margin by $24M per year
We identify enzymes to realize enzymatic conversion of this novel cheap substrate to the correct product

CASE STUDY
A polymerase case from a diagnostics client
Problem
The customer wants a better novel polymerase for Library preparation for NGS
Crowded IP space
Need to precisely identify different sequence patterns in novel enzymes and remove them
Pando Customer Value Proposition:
In 4 months, we have demonstrate 22% of designed proteins showed significant activity, top 4% are already comparable to the market leaders in thermostability, processivity, speed, and fidelity
All enzymes have FTO and no prior-art
CASE STUDY
An enzyme engineering biocatalysiscase from a pharma client
Problem
The customer already uses an enzymatic step to synthesize a small molecule. But the the enzyme activity is low
From the substrate to the product both the conversion rate and the e.e. value have to be greater than 99%, increase enzyme activity by at least 250%
Pando Customer Value Proposition:
In just one round, within the first quarter of the project, our engineered enzyme increased enzymatic activity by over 500% while maintaining the conversion rate and e.e. value > 99%
All enzymes have FTO and no prior-art
CASE STUDY
Metagenomic sourcing biocatalysis cases from pharma clients
Problem
The customer uses 17 chemical steps to synthesize a generic drug. The manufacturing cost is very high
The current substrate is very expensive, the customer made a cheap substitute, but the chemical step can not convert the cheaper substrate to the correct product
Pando Customer Value Proposition:
We replaced 11 chemical steps with one enzymatic step, and enabled our pharma customer to project a 50% reduction in manufacturing costs, increasing their profit margin by $24M per year
We identify enzymes to realize enzymatic conversion of this novel cheap substrate to the correct product